About Dr. Reddy's

Established in 1984, Dr. Reddy's Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities (NCEs).

Pharmaceutical Services & Active Ingredients (PSAI) Pharmaceutical Services & Active Ingredients (PSAI)

Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses

Explore
Global Generics Global Generics

Global Generics, which includes branded and unbranded generics

Explore
Proprietary Products Proprietary Products

Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and Generic Biopharmaceuticals.

Explore

Our Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and paediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand.


Dr. Reddy’sAnnual Report
Dr. Reddy’s
Annual Report
Dr. Reddy’sSustainability Report
Dr. Reddy’s
Sustainability Report